Sarah McDonald, PhD is a scientist at Celdara Medical LLC, a biotechnology company working to transform academic innovations into medicines that cure the world’s most challenging diseases. She works at the bench and leads several programs. She is also part of Celdara Medical’s EDI working group and has been instrumental in developing a comprehensive EDI strategy at Celdara.

See them at OPTIMA22